Sign in

CIK 0002040475 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Drugs Made In America Acquisition II Corp.

Sign in to watch
Ticker
DMII
Exchange
Nasdaq
Industry
Blank Checks
FY end
Dec 31
Entity type
operating
Phone
954-870-3104
Business address
420 LEXINGTON AVENUE, SUITE 1402, NEW YORK, NY, 10170

Securities

  • DMII Ordinary Shares Nasdaq
  • DMIIR Right Nasdaq
  • DMIIU Unit Nasdaq
  1. 8-K Event Material agreement · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Other events
  2. 3 Insider Initial Statement of Ownership
  3. 424B4 Offering Prospectus
  4. EFFECT Other Notice of Effectiveness
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. CERT Other Certification
  11. 8-A12B Other Registration of Securities
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. S-1/A Offering Registration Statement
  16. UPLOAD Other SEC-generated Letter
  17. S-1/A Offering Registration Statement
  18. S-1/A Offering Registration Statement
  19. S-1 Offering Registration Statement
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 2 of 3 · 45 filings